ArticleJournal of pain research2025
Single-Injection Adductor Canal Block Enhances Early Mobilization with Comparable Analgesia to Continuous Infusion in Unicompartmental Knee Arthroplasty: A Retrospective Cohort Study.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Precision and safety advantages of ultrasound-guided nerve blocks in geriatric anesthesia: current status and future prospects.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Adductor canal block (ACB) is commonly used for postoperative analgesia after unicompartmental knee arthroplasty (UKA). However, the comparative benefits of single-injection ACB (SACB) versus continuous ACB (CACB) remain unclear. Methods: In our retrospective cohort study, patients undergoing unilateral, primary UKA were allocated to group CACB or group SACB from January 2016 to December 2023. The primary outcome was the visual analog scale (VAS) for pain. Secondary outcomes included the additional analgesic therapy, activity score, postoperative nausea and vomiting (PONV), complications, and length of stay (LOS). Results: After 1:1 propensity score matching based on age, sex, body mass index (BMI), and preoperative pain score, 35 patients were included in each group (SACB and CACB). At 24 hours postoperatively, the SACB group had a slightly higher VAS pain score compared with the CACB group, though this difference was not statistically significant. The Post-Anesthesia Care Unit (PACU) activity score was significantly higher in the SACB group ( Discussion: CACB did not significantly reduce postoperative pain or improve functional outcomes over three months after UKA compared to SACB. However, SACB was associated with improved immediate postoperative mobility and a shorter LOS, suggesting potential benefits for early recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.